66993-134-97 : NDC 2025 Code

66993-134-97 : Umeclidinium Bromide And Vilanterol Trifenatate ( Umeclidinium And Vilanterol Ellipta )

Additionally :

You can get information about “66993-134-97” NDC code in 66993-134-97 in HTML format

HTML | 66993-134-97 in TXT (Plain Text) format

TXT | 66993-134-97 in PDF (Portable Document Format)

PDF | 66993-134-97 in XML format

XML formats.

NDC Code : 66993-134-97 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "66993-134-97",
    "PackageDescription": "1 TRAY in 1 CARTON (66993-134-97)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
    "NDC11Code": "66993-0134-97",
    "ProductNDC": "66993-134",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Umeclidinium And Vilanterol Ellipta",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Umeclidinium Bromide And Vilanterol Trifenatate",
    "DosageFormName": "POWDER",
    "RouteName": "RESPIRATORY (INHALATION)",
    "StartMarketingDate": "20250411",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA AUTHORIZED GENERIC",
    "ApplicationNumber": "NDA203975",
    "LabelerName": "Prasco Laboratories",
    "SubstanceName": "UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE",
    "StrengthNumber": "62.5; 25",
    "StrengthUnit": "ug/1; ug/1",
    "Pharm_Classes": "Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250411",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}